US 11,890,305 B2
Method and composition for ameliorating drug seeking behavior
Ajibike Omosalewa Salako-Akande, Halethorpe, MD (US)
Filed by Ajibike Omosalewa Salako-Akande, Halethorpe, MD (US)
Filed on Feb. 15, 2022, as Appl. No. 17/671,959.
Application 17/671,959 is a continuation of application No. 16/708,843, filed on Dec. 10, 2019, granted, now 11,246,892, issued on Feb. 15, 2022.
Claims priority of provisional application 62/777,529, filed on Dec. 10, 2018.
Prior Publication US 2022/0339204 A1, Oct. 27, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/00 (2006.01); A61K 35/60 (2006.01); A61P 25/30 (2006.01); A61K 31/4415 (2006.01); A61K 33/08 (2006.01); A61K 33/10 (2006.01); A61K 31/07 (2006.01); A61K 31/375 (2006.01); A61K 31/59 (2006.01); A61K 31/355 (2006.01); A61K 31/122 (2006.01); A61K 31/51 (2006.01); A61K 31/525 (2006.01); A61K 31/455 (2006.01); A61K 31/519 (2006.01); A61K 31/4188 (2006.01); A61K 31/197 (2006.01); A61K 31/714 (2006.01); A61K 33/06 (2006.01); A61K 33/26 (2006.01); A61K 33/42 (2006.01); A61K 33/18 (2006.01); A61K 33/30 (2006.01); A61K 33/34 (2006.01); A61K 33/32 (2006.01); A61K 33/24 (2019.01); A61K 33/20 (2006.01); A61K 33/00 (2006.01); A61K 31/01 (2006.01); A61K 31/05 (2006.01); A61K 31/198 (2006.01)
CPC A61K 35/60 (2013.01) [A61K 31/01 (2013.01); A61K 31/05 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/197 (2013.01); A61K 31/198 (2013.01); A61K 31/355 (2013.01); A61K 31/375 (2013.01); A61K 31/4188 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/59 (2013.01); A61K 31/714 (2013.01); A61K 33/00 (2013.01); A61K 33/06 (2013.01); A61K 33/08 (2013.01); A61K 33/10 (2013.01); A61K 33/18 (2013.01); A61K 33/20 (2013.01); A61K 33/24 (2013.01); A61K 33/26 (2013.01); A61K 33/30 (2013.01); A61K 33/32 (2013.01); A61K 33/34 (2013.01); A61K 33/42 (2013.01); A61P 25/30 (2018.01)] 2 Claims
OG exemplary drawing
 
1. A method for ameliorating drug-seeking behavior in drug addicts who have stopped using the addicted-to drug and who have reestablished non-addict physiological chemical balance, comprising administration of a therapeutically effective amount of a nutritional supplement comprising the following:
 
 
 
 Ingredient Range (g)**
 
 
 
 
 L-Tyrosine 1.44-1.76 g
 
 Fish oil (DHA/EPA) 1.08-1.26 g
 
 Vitamin B6 0.23-0.28 g
 
 Magnesium oxide 0.09-0.11 g
 
 Calcium carbonate 0.18-0.22 g
 
 Vitamin A 3.8-4.6 mg
 
 Vitamin C 160-200 mg
 
 Vitamin D 0.018-0.022 mg
 
 Vitamin E 48.6-59.4 mg
 
 Thiamine 2.7-3.3 mg
 
 Folic Acid 0.9-1.1 mg
 
 Vitamin B12 0.01-0.014 mg.